Tolerability of switch from erenumab to fremanezumab in adults with chronic migraine: a 3-month, single-center, prospective, real-world, observational study
Abstract Objective While erenumab and fremanezumab are effective treatments for migraine prevention, it is unclear whether patients who experience adverse events related to erenumab can tolerate fremanezumab. This study evaluated the tolerability of switching from erenumab to fremanezumab in patient...
שמור ב:
| Principais autores: | , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMC
2025-07-01
|
| סדרה: | The Journal of Headache and Pain |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1186/s10194-025-02087-z |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|